NVDA Q3 Earnings Alert: Why our AI stock picker is still holding Nvidia stockRead More

Euro maintains firm tone on EU joint recovery fund, yen soft

Published 05/19/2020, 09:15 PM
© Reuters. Euro currency bills are pictured at the Croatian National Bank in Zagreb
EUR/USD
-
EUR/JPY
-
EUR/CHF
-
DX
-
SCGLY
-
ILS/UAH
-
MRNA
-

By Hideyuki Sano

TOKYO (Reuters) - The euro held firm on Wednesday, basking in the afterglow of a Franco-German proposal for a common fund that could move Europe closer to fiscal union.

The dollar also edged higher against the safe-haven yen to edge near a five-week high though it was capped by renewed scepticism on coronavirus vaccine developments.

The euro stood flat at $1.0924 (EUR=), having hit a two-week peak of $1.09755 in European trade.

The common currency also fetched 1.0615 franc (EURCHF=), after rising almost 1.0% so far in the week against the safe haven currency while against the yen, it stood near five-week highs of 118.20 yen (EURJPY=).

"The Franco-German agreement is big news. This has made it difficult for speculators to close their short positions on the currency," said Kyosuke Suzuki, director of forex at Societe Generale (OTC:SCGLY).

France and Germany proposed on Monday a 500 billion euro ($543 billion) Recovery Fund to offer grants to regions and sectors hit hardest by the coronavirus pandemic and to allow borrowing by the European Commission on behalf of the whole EU.

The proposals, while facing opposition from wealthier EU members, could move the European Union a step closer to a transfer union that would help mitigate various economic imbalances in the currency bloc.

Also helping the common currency was a survey showing German investor sentiment improved much more than expected in May as concerns eased over the impact of the coronavirus pandemic on Europe's largest economy.

The U.S. dollar tacked on 0.2% against the yen to 107.94 yen, near a five-week high of 108.085 hit in U.S. trade on Tuesday.

The U.S. currency lost traction on Tuesday after a report from medical news website STAT said early data from Moderna Inc's (O:MRNA) COVID-19 vaccine was insufficient, pouring cold water on optimism sparked a day earlier by the company's announcement.

Data showed U.S. homebuilding dropped by the most on record last month and permits for future construction tumbled, a stark reminder of the heavy economic toll exacted by the outbreak.

The dollar index (=USD) stood at 99.571, essentially stuck in its well-worn range since early April.

© Reuters. Euro currency bills are pictured at the Croatian National Bank in Zagreb

Sterling traded at $1.2251 , flat so far on the day while the Australian dollar fetched $0.65385 , after having hit a two-month high of $0.6585 overnight.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.